From left to right: Dr. Mary Gospodarowicz, Medical Director, Princess Margaret Cancer Centre; Dr. Josep Tabernero, Director, Department of Medical Oncology, Vall d’Hebron University Hospital (Barcelona, Spain), Director of Vall d’Hebron Institute of Oncology (VHIO); Dr. Peter Pisters, President and CEO, UHN. (Photo: UHN Photographics)
(TORONTO, Canada – Feb. 27, 2015) – Two internationally acclaimed cancer centres today announced a partnership to accelerate academic and clinical research to advance personalized, targeted therapies against cancer.
The partners – Princess Margaret Cancer Centre, University Health Network, Toronto and Vall d'Hebron Institute of Oncology (VHIO), Barcelona – signed a Memorandum of Understanding (MOU) in Toronto establishing the principles and framework for their collaboration.
Signing on behalf of the Princess Margaret, Medical Director Dr. Mary Gospodarowicz said: "Our organizations share a common purpose and vision to pool our knowledge, broad spectrum of expertise and commitment to research to promote and disseminate best practices and innovation in cancer care globally."
"This is how we can to provide world-class cancer research and the best possible care to benefit patients well beyond the walls of our individual centres."
Read the full press release
